<DOC>
	<DOCNO>NCT02344979</DOCNO>
	<brief_summary>Purpose : To evaluate efficacy safety rHuTPO/rHuIL-11 treatment chemotherapy-induced thrombocytopenia patient NSCLC receive gemcitabine cisplatin carboplatin chemotherapy .</brief_summary>
	<brief_title>The Study rHuTPO/rHuIL-11 Treatment Chemotherapy-induced Thrombocytopenia Patients With NSCLC</brief_title>
	<detailed_description>Inclusion Criteria : 1 . Patients age 18 year -75 year , male female ; 2. histologically cytologically confirm non-small cell lung cancer ; 3. consistent indication chemotherapy 4. decrease platelet appear screen chemotherapy period platelet count le 50 * 109/ L ; 5. expect survival 3 month ; 6. patient must ability understand willingness sign write informed consent ; 7. able follow study follow-up procedure Exclusion Criteria : 1. pregnant lactate woman ; 2. patient severe allergic history biological preparation ; 3. exist serious acute infection without control ; 4 . Patients receive radiotherapy ; 5. 3 metastatic tumor bone find screening period , platelet count restore 100 * 109/ L screen period seventeenth day screen period ; 6. history pulmonary embolism , myocardial infarction patient , thrombus history thrombosis activity past 3 month ; 7 . Sepsis , disseminate intravascular coagulation ( DIC ) ; hypersplenism illness sickness exacerbate thrombocytopenia appear previous cycle chemotherapy ; 8. tumor metastasis find central nervous system ;</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<criteria>Age &gt; 18 year , Male females Patients NSCLC treatment gemcitabine cisplatin carboplatin Platele count ≤ 50×109/L Screening chemo cycle ECOG PS score ≤ 2 The predicted life expectancy ≥3 month Written inform consent Pregnant nursing woman Known history severe anaphylactic reaction biologics Uncontrolled severe infection History bone central nervous system metastasis History platelet disorder Active bleeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>NSCLC</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>thrombocytopenia</keyword>
	<keyword>rhTPO</keyword>
</DOC>